Metraipolis › archive › dc_722412e13e31
Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors — Europe PMC PMID:41374979
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41374979
- DOI
- 10.3390/cancers17233777
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:41:42.070Z
- SHA-256 of the archived text
308a2501ee3790c9290db668b3de291743c66958235b963c57f60b790dc8c278- Stable URL of this page
https://metraipolis.com/documento/dc_722412e13e31
How to cite
Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors — Europe PMC PMID:41374979 — Europe PMC (en), https://europepmc.org/article/MED/41374979 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_722412e13e31 (Metraipolis archive dc_722412e13e31, sha256 308a2501ee3790c9290db668b3de291743c66958235b963c57f60b790dc8c278)
BibTeX
@misc{dc722412e13e31,
title = {Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors — Europe PMC PMID:41374979},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41374979},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_722412e13e31; sha256 308a2501ee3790c9290db668b3de291743c66958235b963c57f60b790dc8c278},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41374979. Agents can read the archived copy with the MCP tool read_document.